How effective has the novel re-engineering of the IL-2 cytokine fusion protein, nemvaleukin, been as far as mitigating side effects and permitting outpatient-based administration and management of this cytokine-based treatment modality?

Name: How effective has the novel re-engineering of the IL-2 cytokine fusion protein, nemvaleukin, been as far as mitigating side effects and permitting outpatient-based administration and management of this cytokine-based treatment modality?
Uploaded: T00:00:00+00:00

CLICK HERE FOR CME CREDIT Back to Symposium

Created by

Presenter

Richard Carvajal, MD

Deputy Physician-in-Chief and Director of Medical OncologyRoy J. and Tara Zuckerberg Professor in Medical OncologyNorthwell Health Cancer InstituteLake Success, NY